Open AccessImplantable Cardioverter Defibrillators and Quality of Life<subtitle>Results From the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation Study</subtitle>
Author(s) -
Rod Passman,
Haris Subačius,
Bernice Ruo,
Andi Schaechter,
Adam Howard,
Samuel F. Sears,
Alan H. Kadish
Publication year - 2007
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.167.20.2226
Subject(s) - medicine , ejection fraction , cardiology , cardiomyopathy , ventricular tachycardia , implantable cardioverter defibrillator , heart failure , quality of life (healthcare) , shock (circulatory) , population , randomization , randomized controlled trial , nursing , environmental health
The Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation study demonstrated that implantable cardioverter defibrillators (ICDs) significantly reduce the risk of sudden cardiac death in patients with nonischemic cardiomyopathy and an ejection fraction of 35% or less, with no statistically significant decrease in overall mortality. The impact of ICD placement and shock on health-related quality of life (HRQL) in this population is unknown.